Practice question

Answer the question and get instant feedback.

ModerateEndocrinologyType 2 diabetes therapy intensificationus-abfmus-abimus-usmle-step-2us-usmle-step-3

A 48-year-old man with obesity (BMI 33 kg/m2), type 2 diabetes, and hypertension presents for follow-up. His hemoglobin A1c is 8.5 percent despite metformin at maximum dose. eGFR is 70 mL/min/1.73 m2. He has no history of heart failure or chronic kidney disease. Which agent is most appropriate to add for additional glycemic control while also promoting weight loss?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.